ACTG SLIM LIVER Findings Published in Annals of Internal Medicine
10 mai 2024 11h13 HE
|
ACTG
Announcing the publication of results from SLIM LIVER (also known as A5371) in the Annals of Internal Medicine.
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure
19 avr. 2024 09h00 HE
|
ACTG
ACTG Announces Launch of Clinical Trial Evaluating Combination of Three Novel Immune-based Therapies for HIV Cure
ACTG CROI Presentation Demonstrates Superiority of HepB-CpG Vaccine Over Conventional Hepatitis B Vaccine Among People Living With HIV Who Have Not Previously Responded to Vaccination
06 mars 2024 15h30 HE
|
ACTG
ACTG at CROI: HepB-CPG Vaccine Outperforms Standard Hepatitis B Vaccine for HIV Patients with Previous Vaccination Failures
ACTG Presents Study at CROI Demonstrating Efficacy of Long-Acting Injectable Treatment Among People Who Had Previously Been Unable to Maintain Viral Suppression on Daily Oral Medication
06 mars 2024 10h45 HE
|
ACTG
ACTG Study Shows Long-Acting Injectable Treatment Effective for Those Struggling with Viral Suppression on Daily Oral Medication
ACTG CROI Presentations Show That Semaglutide Improves Metabolic-Associated Steatotic Liver Disease Among People Living With HIV
05 mars 2024 13h15 HE
|
ACTG
ACTG CROI PRESENTATIONS SHOW THAT SEMAGLUTIDE IMPROVES METABOLIC-ASSOCIATED STEATOTIC LIVER DISEASE AMONG PEOPLE LIVING WITH HIV
ACTG Presents Study at CROI Elucidating Mechanism of CMV on Aging-Related Pathways in HIV
04 mars 2024 10h00 HE
|
ACTG
ACTG PRESENTS STUDY AT CROI ELUCIDATING MECHANISM OF CMV ON AGING-RELATED PATHWAYS IN HIV
ACTG Announces Launch of Clinical Trial Evaluating Drug-Drug Interaction in Shortened Tuberculosis Regimen Among People Living with HIV
14 févr. 2024 11h48 HE
|
ACTG
ACTG Announces Launch of Clinical Trial Evaluating Drug-Drug Interaction in Shortened Tuberculosis Regimen Among People Living with HIV
ACTG Announces Launch of Clinical Trial Evaluating Novel Treatment for Tuberculous Meningitis
07 déc. 2023 15h10 HE
|
ACTG
Regimen Would Decrease Duration of Treatment from Nine to Six Months LOS ANGELES, Dec. 07, 2023 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious...
ACTG Announces Publication of REPRIEVE Trial in New England Journal of Medicine and Presentation at IAS 2023
23 juil. 2023 19h45 HE
|
AIDS Clinical Trials Group Network
LOS ANGELES, July 23, 2023 (GLOBE NEWSWIRE) -- The AIDS Clinical Trials Group (ACTG), a global clinical trials network focused on HIV, tuberculosis, hepatitis B and emerging infectious diseases,...
ACTG Announces Publication of New Insights Into HIV Reservoirs and Prospects for Remission in the Journal of Infectious Diseases
27 mars 2023 16h19 HE
|
AIDS Clinical Trials Group Network
LOS ANGELES, March 27, 2023 (GLOBE NEWSWIRE) -- The AIDS Clinical Trials Group (ACTG), the world’s largest HIV research network, today announced the publication of “Varied Patterns of Decay of...